- Filed
- Nov 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 13, 2024 | 481.27B sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $2.53M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $3.66M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2023 | $6.2M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $3.19M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $12.23M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $3.19M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $23.1M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $3.39M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $11.73M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $3.78M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $30.97M |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 358.19B sh |
| Shares Diluted | Q3 2024 · Sep 30, 2023 | 351.3B sh |
| Capex | Q3 2024 · Sep 30, 2023 | $176.13K |
| Stockholders Equity | Q3 2024 · Sep 30, 2023 | $16.41M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $18.28M |
| Stockholders Equity | Q3 2024 · Dec 31, 2022 | $20.21M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$2.99M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$7.55M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$2.14M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$5.45M |
| Gross Profit restated | Q3 2024 · Sep 30, 2023 | −$614 |
| Cost Of Revenue | Q3 2024 · Sep 30, 2023 | $653 |
| Revenue restated | Q3 2024 · Sep 30, 2023 | $39 |